Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 76

1.

Lifetime exposure to estrogens and Parkinson's disease in California teachers.

Gatto NM, Deapen D, Stoyanoff S, Pinder R, Narayan S, Bordelon Y, Ritz B.

Parkinsonism Relat Disord. 2014 Nov;20(11):1149-56. doi: 10.1016/j.parkreldis.2014.08.003. Epub 2014 Aug 19.

PMID:
25179495
2.

Effect of reproductive factors and postmenopausal hormone use on the risk of Parkinson disease.

Popat RA, Van Den Eeden SK, Tanner CM, McGuire V, Bernstein AL, Bloch DA, Leimpeter A, Nelson LM.

Neurology. 2005 Aug 9;65(3):383-90.

PMID:
16087902
3.

Passive smoking and Parkinson's disease in California Teachers.

Gatto NM, Deapen D, Bordelon Y, Marshall S, Bernstein L, Ritz B.

Parkinsonism Relat Disord. 2017 Dec;45:44-49. doi: 10.1016/j.parkreldis.2017.10.001. Epub 2017 Oct 4.

PMID:
29033298
4.

Hysterectomy, menopause, and estrogen use preceding Parkinson's disease: an exploratory case-control study.

Benedetti MD, Maraganore DM, Bower JH, McDonnell SK, Peterson BJ, Ahlskog JE, Schaid DJ, Rocca WA.

Mov Disord. 2001 Sep;16(5):830-7.

PMID:
11746612
5.

Reproductive factors, exogenous estrogen use, and risk of Parkinson's disease.

Simon KC, Chen H, Gao X, Schwarzschild MA, Ascherio A.

Mov Disord. 2009 Jul 15;24(9):1359-65. doi: 10.1002/mds.22619.

6.

Exposure to estrogen and women's risk for Parkinson's disease: a prospective cohort study in Denmark.

Rugbjerg K, Christensen J, Tjønneland A, Olsen JH.

Parkinsonism Relat Disord. 2013 Apr;19(4):457-60. doi: 10.1016/j.parkreldis.2013.01.008. Epub 2013 Feb 9.

PMID:
23402992
7.

Risk of Parkinson disease in women: effect of reproductive characteristics.

Ragonese P, D'Amelio M, Salemi G, Aridon P, Gammino M, Epifanio A, Morgante L, Savettieri G.

Neurology. 2004 Jun 8;62(11):2010-4.

PMID:
15184606
8.

Caffeine, postmenopausal estrogen, and risk of Parkinson's disease.

Ascherio A, Chen H, Schwarzschild MA, Zhang SM, Colditz GA, Speizer FE.

Neurology. 2003 Mar 11;60(5):790-5.

PMID:
12629235
9.

Implications for estrogens in Parkinson's disease: an epidemiological approach.

Ragonese P, D'Amelio M, Savettieri G.

Ann N Y Acad Sci. 2006 Nov;1089:373-82. Review.

PMID:
17261781
10.

Reproductive factors and Parkinson's disease: a multicenter case-control study.

Nicoletti A, Nicoletti G, Arabia G, Annesi G, De Mari M, Lamberti P, Grasso L, Marconi R, Epifanio A, Morgante L, Cozzolino A, Barone P, Quattrone A, Zappia M.

Mov Disord. 2011 Dec;26(14):2563-6. doi: 10.1002/mds.23951. Epub 2011 Sep 28.

PMID:
21956541
11.

Formulations of hormone therapy and risk of Parkinson's disease.

Lundin JI, Ton TG, LaCroix AZ, Longstreth WT, Franklin GM, Swanson PD, Smith-Weller T, Racette BA, Checkoway H.

Mov Disord. 2014 Nov;29(13):1631-6. doi: 10.1002/mds.26037. Epub 2014 Sep 25.

12.

Lifetime estrogen exposure versus age at menopause as mortality predictor.

Jansen SC, Temme EH, Schouten EG.

Maturitas. 2002 Oct 25;43(2):105-12.

PMID:
12385858
13.

A case control study of women with Parkinson's disease and their fertility characteristics.

Yadav R, Shukla G, Goyal V, Singh S, Behari M.

J Neurol Sci. 2012 Aug 15;319(1-2):135-8. doi: 10.1016/j.jns.2012.05.026. Epub 2012 May 28.

PMID:
22647587
14.

Reproductive factors and clinical features of Parkinson's disease.

Cereda E, Barichella M, Cassani E, Caccialanza R, Pezzoli G.

Parkinsonism Relat Disord. 2013 Dec;19(12):1094-9. doi: 10.1016/j.parkreldis.2013.07.020. Epub 2013 Aug 7.

PMID:
23931933
15.

Female reproductive factors, menopausal hormone use, and Parkinson's disease.

Liu R, Baird D, Park Y, Freedman ND, Huang X, Hollenbeck A, Blair A, Chen H.

Mov Disord. 2014 Jun;29(7):889-96. doi: 10.1002/mds.25771. Epub 2013 Dec 18.

16.

Estrogens reduce and withdrawal of estrogens increase risk of microsatellite instability-positive colon cancer.

Slattery ML, Potter JD, Curtin K, Edwards S, Ma KN, Anderson K, Schaffer D, Samowitz WS.

Cancer Res. 2001 Jan 1;61(1):126-30.

17.

Age-specific effects of hormone therapy use on overall mortality and ischemic heart disease mortality among women in the California Teachers Study.

Stram DO, Liu Y, Henderson KD, Sullivan-Halley J, Luo J, Saxena T, Reynolds P, Chang ET, Neuhausen SL, Horn-Ross PL, Bernstein L, Ursin G.

Menopause. 2011 Mar;18(3):253-61. doi: 10.1097/gme.0b013e3181f0839a.

18.

Postmenopausal estrogen use affects risk for Parkinson disease.

Currie LJ, Harrison MB, Trugman JM, Bennett JP, Wooten GF.

Arch Neurol. 2004 Jun;61(6):886-8.

PMID:
15210525
19.

Menopause and stroke and the effects of hormonal therapy.

Lobo RA.

Climacteric. 2007 Oct;10 Suppl 2:27-31. Review.

PMID:
17882669
20.

Reproductive life characteristics in females affected with Parkinson's disease and in healthy control subjects - a comparative study on Polish population.

Nitkowska M, Czyżyk M, Friedman A.

Neurol Neurochir Pol. 2014;48(5):322-7. doi: 10.1016/j.pjnns.2014.08.004. Epub 2014 Sep 16.

PMID:
25440010

Supplemental Content

Support Center